The Molecular Interrogation: Handbook of Therapeutic Biomarkers in Cancer
Prescribing a targeted cancer drug without testing the patient’s biomarker is equivalent to firing a sniper rifle while blindfolded. If the tumor does not possess the specific genetic mutation the drug is designed to hit, the ,000 treatment is mathematically guaranteed to fail. Handbook of Therapeutic Biomarkers in Cancer is a brutally efficient, highly clinical laboratory manual detailing exactly how to match the drug to the DNA. This volume provides the absolute, non-negotiable pathological blueprints required to execute modern precision oncology.
Mastering the HER2 Amplification
The core philosophy of this text is the mandatory diagnostic test. The authors aggressively detail the mechanics of FISH (Fluorescence In Situ Hybridization). It dictates exactly how a pathologist must physically count the number of HER2 genes inside a breast cancer cell, proving mathematically whether the patient is eligible to receive life-saving Herceptin, or whether the drug will be utterly useless.
Navigating Immune Checkpoint Expression
The book provides a masterclass in predicting immunotherapy response. It dictates the exact laboratory pathways for PD-L1 scoring. It rigorously explores the maddening complexity of reading an immunohistochemistry slide, teaching the clinician exactly how to determine the precise percentage of tumor cells hiding behind the PD-L1 protein shield, legally justifying the prescription of massive-dose Keytruda.
Frequently Asked Questions (FAQs)
Does this book provide surgical protocols for removing tumors?
No, its absolute, exclusive focus is on the *molecular pathology, companion diagnostics, and targeted pharmacology* required before a systemic drug can be administered.
Who is the primary audience?
It is an essential, mandatory daily reference for Medical Oncologists, Molecular Pathologists, Oncology Pharmacists, and Translational Researchers.
